US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 8.970
  • +0.120+1.36%
Trading Mar 28 11:53 ET
490.14MMarket Cap-3410P/E (TTM)

Marinus Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.53%-118M
-23.17%-26.99M
15.09%-25.17M
27.66%-24.36M
-49.98%-41.48M
-103.48%-112.89M
-0.75%-21.91M
-648.68%-29.65M
-46.69%-33.67M
-70.97%-27.66M
Net income from continuing operations
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
475.71%73.29M
-65.52%-39.43M
28.67%-19.36M
Operating gains losses
----
----
----
----
----
-11,345.70%-106.45M
--0
---107.38M
--0
--930K
Depreciation and amortization
31.82%551K
52.44%125K
-10.13%142K
36.56%127K
84.71%157K
17.75%418K
-11.83%82K
73.63%158K
8.14%93K
0.00%85K
Other non cash items
51.91%5.06M
-113.08%-207K
1,141.67%1.79M
381.00%1.82M
35.18%1.66M
212.77%3.33M
397.80%1.58M
-55.28%144K
40.37%379K
690.32%1.23M
Change In working capital
135.60%2.17M
58.39%9.94M
1,522.22%2.19M
47.93%2.18M
13.15%-12.14M
-121.23%-6.09M
63.80%6.28M
-99.38%135K
159.34%1.47M
-345.53%-13.97M
-Change in prepaid assets
54.24%-2.55M
214.52%3.74M
585.12%1.15M
208.02%1.52M
-736.10%-8.96M
-553.81%-5.58M
-716.00%-3.26M
-70.21%168K
-1.88%-1.41M
-392.90%-1.07M
-Change in payables and accrued expense
-43.85%2.11M
109.73%5.67M
200.95%529K
-115.73%-371K
-374.71%-3.72M
-52.12%3.75M
-18.86%2.7M
-285.82%-524K
315.24%2.36M
-114.70%-783K
-Change in other current liabilities
--0
--0
--0
--0
--0
-200.00%-22.16M
--0
--0
--0
---22.16M
-Change in other working capital
-85.40%2.61M
-92.19%534K
3.87%510K
96.74%1.03M
-94.58%544K
4,058.85%17.89M
1,107.95%6.84M
--491K
--521K
--10.05M
Cash from discontinued investing activities
Operating cash flow
-4.53%-118M
-23.17%-26.99M
15.09%-25.17M
27.66%-24.36M
-49.98%-41.48M
-103.48%-112.89M
-0.75%-21.91M
-648.68%-29.65M
-46.69%-33.67M
-70.97%-27.66M
Investing cash flow
Cash flow from continuing investing activities
-127.04%-28.61M
8,084.81%6.47M
-88.77%11.92M
1,593.73%5M
-60,359.30%-52M
7,575.05%105.77M
110.96%79K
12,269.04%106.11M
61.23%-335K
-108.25%-86K
Net PPE purchase and sale
93.14%-110K
-143.04%-34K
93.66%-80K
101.19%4K
--0
44.51%-1.6M
110.96%79K
-44.61%-1.26M
61.23%-335K
80.09%-86K
Net investment purchase and sale
-126.54%-28.5M
--6.5M
-88.82%12M
--5M
---52M
7,184.60%107.38M
--0
--107.38M
--0
--0
Cash from discontinued investing activities
Investing cash flow
-127.04%-28.61M
8,084.81%6.47M
-88.77%11.92M
1,593.73%5M
-60,359.30%-52M
7,575.05%105.77M
110.96%79K
12,269.04%106.11M
61.23%-335K
-108.25%-86K
Financing cash flow
Cash flow from continuing financing activities
-78.65%26.63M
-99.30%661K
4,844.14%25.9M
1,592.86%237K
-100.56%-174K
201.96%124.74M
31,595.96%94.14M
-101.94%-546K
-99.89%14K
32,330.21%31.13M
Net issuance payments of debt
--0
-97.52%737K
43.77%-316K
---247K
-100.59%-174K
45.33%58.51M
--29.67M
-102.01%-562K
--0
--29.4M
Net common stock issuance
-59.95%25.82M
-100.15%-97K
----
----
----
--64.48M
--64.48M
----
----
----
Proceeds from stock option exercised by employees
-55.18%804K
-32.26%21K
1,768.75%299K
3,357.14%484K
--0
49.62%1.79M
-89.56%31K
-84.16%16K
-97.49%14K
610.25%1.73M
Net other financing activities
----
----
----
----
----
71.62%-42K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-78.65%26.63M
-99.30%661K
4,844.14%25.9M
1,592.86%237K
-100.56%-174K
201.96%124.74M
31,595.96%94.14M
-101.94%-546K
-99.89%14K
32,330.21%31.13M
Net cash flow
Beginning cash position
95.69%240.55M
-16.53%140.44M
38.41%127.79M
16.30%146.9M
95.69%240.55M
-11.25%122.93M
15.95%168.25M
-17.93%92.33M
2.31%126.32M
-11.25%122.93M
Current changes in cash
-202.00%-119.98M
-127.48%-19.87M
-83.34%12.65M
43.76%-19.12M
-2,860.82%-93.65M
854.87%117.62M
426.07%72.3M
132.84%75.92M
-209.62%-33.99M
122.56%3.39M
End cash Position
-49.88%120.57M
-49.88%120.57M
-16.53%140.44M
38.41%127.79M
16.30%146.9M
95.69%240.55M
95.69%240.55M
15.95%168.25M
-17.93%92.33M
2.31%126.32M
Free cash flow
-3.02%-118.12M
-22.81%-27.03M
18.27%-25.26M
28.37%-24.36M
-49.52%-41.48M
-96.45%-114.66M
2.07%-22.01M
-782.10%-30.91M
-42.77%-34.01M
-67.04%-27.74M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.53%-118M-23.17%-26.99M15.09%-25.17M27.66%-24.36M-49.98%-41.48M-103.48%-112.89M-0.75%-21.91M-648.68%-29.65M-46.69%-33.67M-70.97%-27.66M
Net income from continuing operations -613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M475.71%73.29M-65.52%-39.43M28.67%-19.36M
Operating gains losses ---------------------11,345.70%-106.45M--0---107.38M--0--930K
Depreciation and amortization 31.82%551K52.44%125K-10.13%142K36.56%127K84.71%157K17.75%418K-11.83%82K73.63%158K8.14%93K0.00%85K
Other non cash items 51.91%5.06M-113.08%-207K1,141.67%1.79M381.00%1.82M35.18%1.66M212.77%3.33M397.80%1.58M-55.28%144K40.37%379K690.32%1.23M
Change In working capital 135.60%2.17M58.39%9.94M1,522.22%2.19M47.93%2.18M13.15%-12.14M-121.23%-6.09M63.80%6.28M-99.38%135K159.34%1.47M-345.53%-13.97M
-Change in prepaid assets 54.24%-2.55M214.52%3.74M585.12%1.15M208.02%1.52M-736.10%-8.96M-553.81%-5.58M-716.00%-3.26M-70.21%168K-1.88%-1.41M-392.90%-1.07M
-Change in payables and accrued expense -43.85%2.11M109.73%5.67M200.95%529K-115.73%-371K-374.71%-3.72M-52.12%3.75M-18.86%2.7M-285.82%-524K315.24%2.36M-114.70%-783K
-Change in other current liabilities --0--0--0--0--0-200.00%-22.16M--0--0--0---22.16M
-Change in other working capital -85.40%2.61M-92.19%534K3.87%510K96.74%1.03M-94.58%544K4,058.85%17.89M1,107.95%6.84M--491K--521K--10.05M
Cash from discontinued investing activities
Operating cash flow -4.53%-118M-23.17%-26.99M15.09%-25.17M27.66%-24.36M-49.98%-41.48M-103.48%-112.89M-0.75%-21.91M-648.68%-29.65M-46.69%-33.67M-70.97%-27.66M
Investing cash flow
Cash flow from continuing investing activities -127.04%-28.61M8,084.81%6.47M-88.77%11.92M1,593.73%5M-60,359.30%-52M7,575.05%105.77M110.96%79K12,269.04%106.11M61.23%-335K-108.25%-86K
Net PPE purchase and sale 93.14%-110K-143.04%-34K93.66%-80K101.19%4K--044.51%-1.6M110.96%79K-44.61%-1.26M61.23%-335K80.09%-86K
Net investment purchase and sale -126.54%-28.5M--6.5M-88.82%12M--5M---52M7,184.60%107.38M--0--107.38M--0--0
Cash from discontinued investing activities
Investing cash flow -127.04%-28.61M8,084.81%6.47M-88.77%11.92M1,593.73%5M-60,359.30%-52M7,575.05%105.77M110.96%79K12,269.04%106.11M61.23%-335K-108.25%-86K
Financing cash flow
Cash flow from continuing financing activities -78.65%26.63M-99.30%661K4,844.14%25.9M1,592.86%237K-100.56%-174K201.96%124.74M31,595.96%94.14M-101.94%-546K-99.89%14K32,330.21%31.13M
Net issuance payments of debt --0-97.52%737K43.77%-316K---247K-100.59%-174K45.33%58.51M--29.67M-102.01%-562K--0--29.4M
Net common stock issuance -59.95%25.82M-100.15%-97K--------------64.48M--64.48M------------
Proceeds from stock option exercised by employees -55.18%804K-32.26%21K1,768.75%299K3,357.14%484K--049.62%1.79M-89.56%31K-84.16%16K-97.49%14K610.25%1.73M
Net other financing activities --------------------71.62%-42K----------------
Cash from discontinued financing activities
Financing cash flow -78.65%26.63M-99.30%661K4,844.14%25.9M1,592.86%237K-100.56%-174K201.96%124.74M31,595.96%94.14M-101.94%-546K-99.89%14K32,330.21%31.13M
Net cash flow
Beginning cash position 95.69%240.55M-16.53%140.44M38.41%127.79M16.30%146.9M95.69%240.55M-11.25%122.93M15.95%168.25M-17.93%92.33M2.31%126.32M-11.25%122.93M
Current changes in cash -202.00%-119.98M-127.48%-19.87M-83.34%12.65M43.76%-19.12M-2,860.82%-93.65M854.87%117.62M426.07%72.3M132.84%75.92M-209.62%-33.99M122.56%3.39M
End cash Position -49.88%120.57M-49.88%120.57M-16.53%140.44M38.41%127.79M16.30%146.9M95.69%240.55M95.69%240.55M15.95%168.25M-17.93%92.33M2.31%126.32M
Free cash flow -3.02%-118.12M-22.81%-27.03M18.27%-25.26M28.37%-24.36M-49.52%-41.48M-96.45%-114.66M2.07%-22.01M-782.10%-30.91M-42.77%-34.01M-67.04%-27.74M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg